What a busy week for Prague.bio! Joining the business mission accompanying the Czech president to Switzerland was definitely one of the highlights! 🌟 A big thank you to the Hospodářská komora České republiky for inviting us, and to Petra Kinzlova for representing our association. We're pleased to see that science and research are clearly priorities for our president, Petr Pavel. It truly has a positive impact!
O nás
Prague.bio was founded in 2023 as a professional association with the vision to integrate R&D, innovation, business, and policy-making activities in the field of biotech in the city of Prague and the broader region. Prague.bio Conference offers a unique meeting of representatives from science and business to exchange their experiences in the development of new drugs, diagnostics, medical technologies and other areas of biotechnology.
- Web
-
https://www.prague.bio/
Externí odkaz pro organizaci Prague.bio
- Obor
- Biotechnologický výzkum
- Velikost společnosti
- 2 – 10 zaměstnanců
- Ústředí
- Prague, Czech Republic
- Typ
- Neziskové organizace
Lokality
-
Primární
Získat instrukce na cestu
Prague, Czech Republic, CZ
Zaměstnanci společnosti Prague.bio
Aktualizace
-
Hopefully see you soon in Prague, BIO-Europe! You're always welcome EBD Group 😊
And that's a wrap! It was a pleasure representing Prague.bio once again at BIO-Europe. If the rumors are true, then the future of BIO-Europe is Prague, right? :) Special thanks to Julie Proft and Martin Opatrný for their fantastic support and collaboration. I’d also like to recognize everyone from IOCB Tech, i&i Prague, i&i Biotech Fund, Bioinova, a.s., SOTIO Biotech, DIANA Biotechnologies, and Deep MedChem who contributed to this event’s success. Looking forward to seeing you all in 2025—in Milan and Vienna!
-
-
News from the business mission to Switzerland and our CEO Petra Kinzlova who is one of the attendees 👉 Our mission continues today in Basel, biotech capital of Switzerland! 🇨🇭 We were touring the Biozentrum, University of Basel, a center known for groundbreaking research in molecular biology and biotechnology. And we also had an exclusive visit to pharmaceutical giant Roche, which offered us insights into cutting-edge research in biotech and pharmaceuticals. The upcoming agenda includes a roundtable discussion on funding opportunities for biotech and life sciences, a key area of growth for both Switzerland and the Czech Republic. And why is Switzerland important to us❓🤔 Switzerland represents an extraordinary opportunity for Prague.bio to connect with one of the most innovative biotech ecosystems in the world. This mission is not just about strengthening commercial ties; it's about fostering collaborations that can drive scientific progress and bolster the international competitiveness of Czech biotech. By connecting with top Swiss institutions and industry leaders, we’re opening doors for new ideas, partnerships, and growth. Foto: Petra Kinzlová, Kapaji
-
-
Our CEO, Petra Kinzlova is attending a business mission accompanying the official visit of Czech President Petr Pavel to Switzerland 🇨🇭 The business portion of the program focuses on biotechnology 🧬 and the cooperation between our countries in the field of life sciences 🤝Today's agenda includes the Swiss-Czech Biotechnology and Pharmaceutical Business Forum, which was opened by Czech President and Swiss Confederation President Viola Amherd. The next phase of the program will involve networking with relevant partners, followed by a visit to Basel. We will keep you posted! 🙂
-
-
Hello from Stockholm! 🙋♂️ 🇸🇪 We're attending BIO-Europe a key biotechnology event in Europe. You can meet our Jiri Fusek at booth no. 49 🤝 together with i&i Prague, SOTIO Biotech, i&i Biotech Fund, DIANA Biotechnologies, Bioinova, a.s., IOCB Tech, Deep MedChem. And we were pleased to kick off the upcoming busy days by meeting with Kristýna Ronnestål from the Embassy of the Czech Republic in Stockholm today.
-
-
Rezervujte si v kalendáři termín 13. listopadu dopoledne❗📆 Zveme vás spolu s Wolf Theiss, Czech Private Equity and Venture Capital Association (CVCA) a Kristýna & Mikuláš advokáti s.r.o. na pracovní snídani 🥐 ☕. Probereme téma investic do biotechnologií, trendy ve výzkumu a také budoucnost investičních příležitostí. Těšíme se na setkání! 🙂 Kdy: 13. listopadu 2024, 08:30 - 11:00 Kde: Butterfly Karlín - Wolf Theiss, Pernerova 691/42 Registrace 👉 📩 registration.prague@wolftheiss.com
-
-
Our CEO Petra Kinzlova is attending the VVKL Conference for the Development, Production, and Control of Pharmaceuticals in Prague. We’re pleased to expand our network in the essential field of drug production. Thank you Tomáš Rotrekl for the invitation, and thanks to everyone who stopped at our booth!
-
-
You can meet us at upcoming BIO-Europe in Stockholm! 🇸🇪 Contact us to schedule a meeting 🤝
Come see us at BIO-Europe, November 4–6, 2024, in Stockholm, Sweden - Prague.bio will be at the booth #49 together with IOCB Tech, i&i Prague, i&i Biotech Fund, Bioinova, a.s., DIANA Biotechnologies, and SOTIO Biotech. Register here: https://lnkd.in/eFyZtxvU Informa Connect
-
-
Are you interested in feedback from a global R&D player in biopharmaceutical industry❓Go for it❗Register for Takeda’s R&D Science Day 2024 in Vienna. The event focuses on startups, subject matter experts and application-oriented academic researchers. It is open to all Czech partners as well. Registration ends TOMORROW so don't miss your chance 😊
Reminder: Apply by October 24 and meet Takeda's experts in #Vienna on November 28, 2024! LISAvienna is pleased to collaborate with Takeda and invites you to participate in the second Takeda R&D Science Day in Vienna. This is a great opportunity to both gain knowledge on innovations that are of interest to Takeda and to get feedback on Chemistry, Manufacturing, and Controls (CMC) related products, services, and solutions, from the perspective of a global R&D player in the biopharmaceutical industry. Takeda’s R&D Science Day 2024 focuses on #startups, subject matter experts and application-oriented academic researchers from across Austria. Takeda is particularly interested in process development technologies for biopharmaceuticals, from new sensors to digital process control, automated solutions and robotics in the lab, as well as solutions for making process development more sustainable, i.e. using less raw material and minimizing carbon footprint. Technologies can range from #prototype and #proofofconcept stages to #readytouse solutions. How to participate? We ask you to submit non-confidential information in the form of 3-5 slides as well as 3-5 questions you would like to discuss with Takeda’s experts at RnD.Austria@takeda.com https://lnkd.in/dcK7bhtF
-
-
Why should young scientists consider creating startups and monetizing their work❓🤔 Jiri Moos from i&i Prague, one of our members, highlights two key motivations. 1️⃣ The first is humanitarian — science should benefit people and society, and its results can inspire further research. 2️⃣ The second is experiential. Working in a startup offers invaluable knowledge that continuously propels individuals forward. In countries like Germany and Austria, such experience makes these individuals highly sought-after in the job market. For more valuable insights, check out the interview published by CHEMAGAZÍN 👉 https://lnkd.in/dCqaWmfa
-